Opendata, web and dolomites

TS4NC SIGNED

TS4NC: Therapeutic S4N Chelation targeting Alzheimer's Disease.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TS4NC project word cloud

Explore the words cloud of the TS4NC project. It provides you a very rough idea of what is the project "TS4NC" about.

redox    linked    complexes    back    boost    act    inhibit    despite    beta    normal    hypotheses    protein    class    professional    helping    greatest    terminus    aggregation    agents    organism    stress    cells    last    ions    brain    career    efforts    motif    clinical    metal    academia    put    activation    s4n    inflammatory    strategy    homeostasis    active    failed    contrary    square    ad    aggregates    eliminating    oxidative    atcun    anti    natural    conclude    arrest    equally    redistributing    neurons    circulation    light    peptide    simply    copper    4n    treatment    horizons    synergistic    industry    mpacs    physiological    carry    planar    enormous    assisting    selectivity    regulation    releasing    neuroglia    forms    ts4nc    herein    reduce    restoration    discovery    discovering    chelating    s4ns    consideration    cascade    maturity    cu    lies    significantly    compounds    drug    decade    scientific    carriers    attenuating    mimics    neuronal    affinity    peptides    prevailing    alzheimer    candidate    amyloid    mcsa    multifunctional    trials    delivering    cycles    sequester    nonregulated    shed    biometal    neuroprotection    novelty    pharmaceutical    metals    disease    fellowship    perform   

Project "TS4NC" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 212˙933 €
 EC max contribution 212˙933 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2020
 Duration (year-month-day) from 2020-09-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 212˙933.00

Map

 Project objective

Despite enormous research efforts across academia and pharmaceutical industry, all clinical trials over the last decade have failed in finding a treatment for Alzheimer’s Disease (AD) which remains one of the greatest challenges in drug discovery. Taking consideration all together three prevailing AD hypotheses: Amyloid Cascade, Metal Ions and Oxidative Stress, researchers conclude that loss of neurons is due to a high level of oxidative stress produced by nonregulated redox active metal ions such as copper linked to different forms/aggregates of amyloid-β (Aβ) peptides. Therefore, the regulation of metal homeostasis is a key target for drug development. Herein, we propose a new class of multifunctional agents – S4Ns, which not only sequester Cu ions from their Aβ complexes and arrest their redox cycles, thus reduce oxidative stress in the neuronal cells, inhibit Aβ aggregation, inhibit neuroglia activation and provide anti-inflammatory effects, delivering overall neuroprotection, but also put Cu back into normal physiological circulation by releasing Cu to natural Cu-carriers. The key novelty of this approach lies in that S4N mimics the N-terminus of Aβ4-x peptide (ATCUN motif), providing 4N square planar Cu(II) coordination with high affinity and selectivity. In general, S4Ns do not act as traditional chelating agents by simply eliminating metals from the organism, on the contrary they perform as Metal–Protein Attenuating Compounds (MPACs) by redistributing and assisting in the restoration of brain biometal homeostasis. This synergistic but novel strategy will allow us to carry out a comprehensive study of the new compounds and shed light into discovering promising drug candidate. Of equally importance, TS4NC MCSA will open new research horizons and significantly boost scientific career of the applicant, by helping her to reach professional maturity during the fellowship.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TS4NC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TS4NC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Widow Spider Mating (2020)

Immature mating as a novel tactic of an invasive widow spider

Read More  

TARGET SLEEP (2020)

Boosting motor learning through sleep and targeted memory reactivation in ageing and Parkinson’s disease

Read More  

ASIQS (2019)

Antiferromagnetic spintronics investigated by quantum sensing techniques

Read More